Drug recall · March 24, 2021
Gabapentin Oral Solution recall
Why: Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed during 6 month stability testing
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Gabapentin Oral Solution, 250 mg/5 mL, 5 mL per unit dose cup, four unit dose cups per tray, For Institutional Use Only, Rx only, Hi-Tech Pharmacal Co., Inc, Amityville, NY 11701, NDC Tray: 50383-311-07; NDC Unit Dose Cup 50383-311-07
- Lots / codes
Lot 369409, Exp. Date 05/2021; Lot 372393, Exp. Date 01/2022; Lot 373112, Exp. Date 04/2022
- Quantity
- 8,183 unit dose cups
- Company
- Akorn, Inc., Lake Forest, IL
- Distribution
- Nationwide USA
- Initiated
- March 8, 2021 · Voluntary: Firm initiated
- Classified
- March 16, 2021
- Reported
- March 24, 2021
- Ended
- August 9, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Gabapentin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.